- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Human Papilloma Virus in Hong Kong
Total 644 results
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of... and other collaboratorsActive, not recruitingCOVID-19United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Gilead SciencesCompletedHIV Infections | HIVUnited States, Puerto Rico
-
Tibotec Pharmaceuticals, IrelandCompletedHIV InfectionUnited States, Australia, France, United Kingdom, Germany, Spain, Belgium, Portugal, Canada, Argentina, Brazil, Austria, Hungary
-
GlaxoSmithKlineActive, not recruitingHerpes GenitalisUnited States, France, Italy, Spain, Finland, United Kingdom
-
NovavaxActive, not recruitingCOVID-19Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
Invivyd, Inc.TerminatedCOVID-19United States, Argentina, Czechia, Georgia, Germany, Moldova, Republic of, Poland, Romania, Ukraine
-
Boehringer IngelheimCompletedHIV InfectionsNetherlands, United States, Canada, Italy, Spain, Australia, Germany, France, United Kingdom
-
Gilead SciencesCompletedHIV Infections | HIVUnited States, Netherlands, Spain, Mexico, France, Thailand, Australia, United Kingdom, Dominican Republic
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
Daniel BenjaminNational Center for Advancing Translational Sciences (NCATS); Biomedical Advanced...CompletedCovid19United States, Brazil, Argentina, Mexico, Peru
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaboratorsCompletedCovid19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Australia, Canada, Puerto Rico
-
ModernaTX, Inc.Active, not recruitingCytomegalovirus InfectionUnited States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
-
GlaxoSmithKlineCompletedHerpes SimplexUnited States, Australia, Spain, Romania, United Kingdom, Belgium, Canada, Estonia, France, Hungary, New Zealand, Sweden, Netherlands, Norway, Greece, Denmark, Iceland, Lithuania
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1United States, France, United Kingdom, China, Belgium, Germany, Spain, Chile, Mexico, Portugal, Costa Rica, Panama, South Africa, Canada, Brazil, Puerto Rico, Russian Federation, Thailand, Australia, India
-
Gilead SciencesCompletedHIV Infections | HIVUnited States, Spain, Puerto Rico, Australia, Thailand, Brazil, France, Belgium, Canada, Dominican Republic, United Kingdom, Germany, Netherlands, Italy, Austria, Denmark, Mexico, Portugal, Switzerland
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV InfectionsUnited States, Germany, Netherlands, Spain, France, Canada, United Kingdom, Italy, South Africa, Russian Federation, Japan
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Gilead SciencesCompletedHIV Infections | HIVCanada, United States, Puerto Rico, Thailand, Australia, France, Belgium, United Kingdom, Germany, Italy, Austria, Mexico, Portugal, Switzerland, Denmark, Netherlands, Sweden
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
ViiV HealthcareJanssen Research and DevelopmentActive, not recruitingHIV InfectionsUnited States, Germany, Spain, France, Canada, Korea, Republic of, Italy, South Africa, Australia, Russian Federation, Mexico, Sweden, Argentina
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV InfectionsUnited States, Germany, Spain, France, Australia, Canada, Belgium, Netherlands, United Kingdom, Japan
-
Gilead SciencesCompletedHIV Infections | HIVCanada, United States, Spain, Puerto Rico, France, Switzerland, Australia, Germany, United Kingdom, Sweden, Brazil, Austria, Thailand, Netherlands, Belgium, Dominican Republic, Portugal, Italy, Denmark, Mexico
-
Gilead SciencesCompletedHIV InfectionCanada, Germany, United States, Spain, France, Australia, Puerto Rico, Italy, Belgium, Mexico, Switzerland, Portugal, Netherlands, United Kingdom
-
Tibotec Pharmaceuticals, IrelandCompletedHIV InfectionUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Argentina, Chile, Mexico, Portugal, Malaysia, Panama, South Africa, Canada, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Hungary, Denmar... and more
-
GlaxoSmithKlineCompleted
-
ModernaTX, Inc.Active, not recruitingCOVID-19United States, United Kingdom, Canada
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Belgium, Botswana, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Russian Federation, South Africa, Spain, Switzerland, United Kingdom
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Bristol-Myers SquibbNo longer availableHIV InfectionsUnited States, Puerto Rico
-
Tibotec Pharmaceuticals, IrelandApproved for marketingHIV InfectionsUnited States, Belgium, Germany, Taiwan, Spain, Switzerland, Mexico, Slovenia, Malaysia, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary, Luxembourg, Venezuela
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Hematopoietic and Lymphatic System NeoplasmUnited States, Canada, Puerto Rico